A cute renal failure is defined as a rapid decrease in the glomerular filtration rate, occurring over a period of minutes to days. Because the rate of production of metabolic waste exceeds the rate of renal excretion in this circumstance, serum concentrations of markers of renal function, such as urea and creatinine, rise. The causes of acute renal failure are classically divided into three categories: prerenal, postrenal (or obstructive), and intrinsic. Prerenal azotemia is considered a functional response to renal hypoperfusion, in which renal structure and microstructure are preserved. Postrenal azotemia -obstruction of the urinary tract -is initially accompanied by few microscopical changes (early hydronephrosis, with enlargement of the pelvic cavity and minimal distention or blunting of the renal papilla) or none. In contrast, intrinsic renal azotemia is due to parenchymal injury of the blood vessels, glomeruli, tubules, or interstitium. In prerenal and postrenal azotemia, complete recovery may be seen 1 to 2 days after relief of the offending lesion, provided that normal perfusion or urinary outflow is reestablished before structural changes occur.
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creatinine level (0.3 to 0.4 mg per deciliter [26.5 to 35.4 μmol per liter]) have a 70% greater risk of death than persons without any increase. 5 This article reviews the renal response to ischemia, notes the risk factors for the development of nor motensive ischemic acute renal failure, and dis cusses the diagnosis of this condition.
R ena l R e sp onse t o Is che mi a
The salient feature of the renal response to a drop in perfusion pressure is autoregulation -main tenance of normal blood flow and glomerular filtration rate, even with mean arterial pressure as low as 80 mm Hg (Fig. 1) . 6 Each of the million or so glomeruli per kidney has an afferent (incom ing) and an efferent (outgoing) arteriole, and pres sure within the glomerular capillaries is affected by the resistances in these two arterioles as they respond to a variety of vasoconstrictor and vaso dilatory factors, including a myogenic stretch reflex in the afferent arteriole. Autoregulation dur ing a decrease in renalartery pressure derives mainly from a drop in afferent glomerular arterio lar resistance, mediated in large part by prosta glandins ( Fig. 2A and 2B ). This drop in afferent resistance sustains glomerular capillary pressure, the driving force of filtration. Glomerular capil lary pressure is also partly supported by an in crease in efferent glomerular arteriolar resistance, mediated largely by angiotensin II. [7] [8] [9] As renal perfusion pressure drops below the autoregulatory range, endogenous vasoconstric tors increase afferent arteriolar resistance. This reduces glomerular capillary pressure and the glomerular filtration rate, resulting in functional prerenal azotemia. 7, 9, 10 The postglomerular cap illary bed, which perfuses the tubules, has dimin ished blood flow and pressure, but the tubules remain intact. However, increasing severity and duration of ischemia may cause structural tubular injury, further impairing renal function. Sloughed tubular epithelial cells and brushborder-mem brane debris form casts that obstruct tubules, and experimental data indicate that glomerular filtrate leaks from the tubular lumen across de nuded tubular walls into capillaries and the circu lation (a phenomenon called backleak). 3, [9] [10] [11] In addition, impaired sodium reabsorption by in jured tubular epithelial cells increases the sodium concentration in the tubular lumen. The increased intratubular sodium concentration polymerizes Tamm-Horsfall protein, which is normally secret ed by the loop of Henle, forming a gel and con tributing to cast formation. 10, 12 The mechanism whereby ischemia and oxygen depletion injure tubular cells starts with ATP de pletion, which activates a number of critical alter ations in metabolism (Fig. 3) . 13, 14 Cytoskeletal disruption leads to loss of brushborder micro villi and cell junctions and to mislocation of inte grins and sodium-potassium ATPase from the basal surface to the apical surface. As a result, brushborder membranes and cells slough and may obstruct tubules downstream. ATP depletion also activates harmful proteases and phospho lipases, which, with reperfusion, cause oxidant injury to tubular cells. Similar damage occurs in endothelial cells of the peritubular capillaries, especially in the outer medulla, which is margin ally oxygenated under normal circumstances. This oxidant injury, together with a shift in the balance of vasoactive substances toward vasocon strictors such as endothelin, results in vasocon striction, congestion, hypoperfusion, and expres sion of adhesion molecules. 14 The expression of adhesion molecules, in turn, initiates leukocyte infiltration, augmented by proinflammatory and chemotactic cytokines generated by ischemic tu bular cells. These leukocytes obstruct the micro circulation and release cytotoxic cytokines, reac tive oxygen species, and proteolytic enzymes, which damage the tubular cells. 14 This tubular damage is commonly known as acute tubular necrosis. The term is misleading, however, because only some tubular cells are ne crotic; most are viable (either healthy or revers ibly injured), and some are apoptotic (i.e., under going an orderly programmed death). "Ischemic acute kidney" and "acute tubular injury" have been proposed as better terms 14 ; neither of these newer terms is in common use.
Fac t or s Incr e a sing R ena l Sus cep t ibil i t y t o Is che mi a
The kidneys are most vulnerable to moderate hypo perfusion when autoregulation is impaired (Fig. 1) , which occurs most often when afferent arteriolar resistance does not decrease appropriately or even increases (Table 1 ). This phenomenon may be seen in elderly patients or in patients with atherosclero sis, hypertension, or chronic renal failure, in whom hyalinosis and myointimal hyperplasia cause structural narrowing of the arterioles. 7, 9, 15 In creased susceptibility to renal ischemia may also occur in malignant hypertension because of inti mal thickening and fibrinoid necrosis of the small arteries and arterioles. 16 In addition, in chronic kidney disease, afferent arterioles in the function ing glomeruli become dilated, which increases their filtration rate (hyperfiltration). Although an increased glomerular filtration rate per nephron compensates for the loss of nephrons, the inabil ity to vasodilate further markedly impairs the kid ney's ability to autoregulate the glomerular filtra tion rate in lowperfusion states. 17 Failure of afferent resistance to decrease can also occur when a patient is receiving nonsteroi dal antiinflammatory drugs (NSAIDs) or cyclo oxygenase2 (COX2) inhibitors, which reduce the synthesis of vasodilatory prostaglandins in the kidneys (Fig. 2C) . 16, [18] [19] [20] 801 aggerated drop in the glomerular filtration rate -for example, when angiotensin II does not raise efferent resistance in patients who are receiving angiotensinreceptor blockers or angiotensincon verting-enzyme (ACE) inhibitors (Fig. 2D) . 15, 16, [29] [30] [31] Narrowing of the main renal arteries due to atherosclerosis can increase susceptibility to renal ischemia. In the case of unilateral renalartery stenosis, the contralateral, normally perfused kid ney maintains the glomerular filtration rate; how ever, renal failure may occur if renalartery steno sis in a solitary kidney or in both kidneys is greater than 70% of the lumen. 16 Renovascular insufficiency affecting the total renal mass may not reduce poststenotic perfusion pressure enough to impair glomerular filtration, but lowering blood pressure with antihypertensive therapy can worsen ischemia and reduce renal function. 32 L ow-Per f usion S tate s in Nor mo tensi v e R ena l Fa ilur e
The cause of classic ischemic acute renal failure is hypovolemic, cardiogenic, or distributive shock, with systolic blood pressure typically dropping below 90 mm Hg. Normotensive renal failure usually involves milder degrees of these lowper fusion processes (Table 2) , but azotemia occurs because of factors that increase renal susceptibil ity to ischemia, as described above (Table 1) .
A less common mechanism for normotensive renal failure is severe hypoperfusion in the pres ence of increased levels of vasoconstrictive sub stances that limit the drop in blood pressure but that may occasionally increase the measured blood pressure. Hypoperfusion may be systemic; for example, in acute myocardial infarction or acute pulmonary edema, low cardiac output may be accompanied by stable or even elevated blood pressure mediated by sympathetic discharge. 33, 34 Hypercalcemia may increase afferent glomerular arteriolar resistance, as mentioned above, and may lead to marked hypovolemia because it may increase renal fluid losses. Hypercalcemia may simultaneously cause systemic vasoconstriction, which may paradoxically maintain or increase blood pressure. 23, 24 Conversely, the severe hypoperfusion may be local: in renalartery stenosis, the poststenotic drop in blood pressure causes intrarenal ischemia but is accompanied by hypertension from hyper volemia or renin release into the circulation. Smallvessel disease in malignant hypertension similarly leads to renal ischemia with increased renin secretion, which worsens the hypertension.
Di agnosis of Nor mo tensi v e Is che mic Acu te R ena l Fa ilur e
Common conditions in which normotensive is chemic acute renal failure may develop include hypertension, chronic kidney disease, and old age, all of which are associated with narrowing and blunted vasodilatory capacity of renal vessels. Other conditions include cirrhosis, infection, myo cardial infarction, and congestive heart failure, as well as decreased intake of food, which can reduce renal perfusion. In addition, diuretics re duce extracellular volume, which can compromise cardiac output, and medications such as ACE in hibitors and NSAIDs interfere with autoregula tion. In classic ischemic acute renal failure, when a patient goes into shock, the physician should be vigilant in looking for a decrease in urinary output and an increase in the serum creatinine concentration. In the normotensive variant, when the urinary output decreases or the creatinine concentration increases, the clinician should look for the presence of a lowperfusion state that may not have been readily apparent. On the first day during which the creatinine concentration in creases, the blood pressure is usually noted to be below its usual level. In persons who have under lying hypertension, blood pressure decreases from high to normal (e.g., a drop in systolic blood pres sure from 160 to 118 mm Hg). Since patients are normotensive when renal failure occurs, the de crease in blood pressure may be overlooked. Fre quently the patient's usual blood pressure is not recorded alongside current blood pressures; the usual blood pressure must be ascertained from medical records and compared with the blood pressures when the serum creatinine concentra tion began to rise. In patients with hypovolemia, blood pressure must often be measured in the up right position to confirm the degree and ortho static nature of the decline in blood pressure.
The cause of the decline in blood pressure may not be apparent. The following two scenarios are not uncommon. In the first, a patient has what turns out to be early sepsis but at the onset does not have fever or any localizing symptoms. Such patients usually have one or more of the follow ing signs or symptoms: hypothermia, confusion, cool extremities, leukocytosis, "bandemia" (an elevated level of band forms of white cells), leuko penia, or unexplained lactic acidosis. Especially in patients with relative hypotension and acute renal failure, any of these clinical pictures should lead the clinician to search for an occult infec tion, using physical examination, imaging, and microbiologic studies.
Alternatively, a patient in stable condition who is receiving diuretics for hypertension or conges tive heart failure may have anorexia and stop eat ing for some reason or may otherwise have de creased salt intake. Progressive negative sodium balance results in volume depletion and a down ward drift in blood pressure. Patients may not be aware of decreases in oral intake or may not volunteer the information spontaneously. Thus, the clinician needs to question the patient, family, and caregivers about recent weight loss or changes in diet.
In addition to watching for lowperfusion states, clinicians should try to identify suscepti bility factors for renal ischemia (Table 1) . Be cause normotensive renal failure is multifactorial, several lowperfusion states and susceptibility fac tors may be present. It is important to ask about the patient's use of overthecounter NSAIDs that might change renal perfusion and to obtain a measurement of the serum calcium concentra tion, corrected for any degree of hypoalbumin emia that is present. Sepsis, hypercalcemia, and the hepatorenal syndrome may all cause both low perfusion states and increased afferent arteriolar resistance. [21] [22] [23] [24] [25] [26] Susceptibility factors may sometimes result in ischemic acute renal failure in the absence of a lowperfusion state. In these cases, the factors result in severe enough renal vasoconstriction to cause a critical reduction in renal perfusion. Ex amples are radiocontrast agents given to patients with chronic renal failure 28 and cyclosporine, ta crolimus, 27 NSAIDs, 35 or COX2 inhibitors 36 given in high or supratherapeutic doses.
Patients with malignant hypertension, renal artery stenosis in a solitary kidney, or bilateral renalartery stenosis have severe hypertension on presentation but also have compromised renal perfusion. As high blood pressure is controlled, renal function may worsen because of a critical drop in glomerular capillary pressure. 16, [30] [31] [32] The 
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Once lowperfusion states and susceptibility factors are recognized, a tentative diagnosis of normotensive renal failure can be made, supported by laboratory findings and a response to therapy.
L a bor at or y Findings
Lowperfusion states trigger the body's water and sodiumconserving mechanisms. Thus, by the time glomerular capillary pressure and glomer ular filtration rate drop, the renal tubule is re absorbing more water and sodium, which also increases passive reabsorption of urea. There is experimental evidence that this increase in reab sorption is facilitated by increased expression of urea transporters in the collecting duct, mediated by high plasma vasopressin concentrations. 37 As a result of these changes, the specific gravity of the urine often increases to 1.015 or higher, while urinary sodium and urea excretion decrease (urinary sodium, <20 mmol per liter; fractional excretion of sodium, <1%; and fractional excre tion of urea, <35%), and the ratio of blood urea nitrogen to creatinine rises from the usual value of 10:1 to 20:1 or higher. 3,9,10,38 These laboratory findings strongly suggest the presence of renal hypoperfusion, even with a blood pressure in the normal range.
If further ischemia causes acute tubular necro sis, the injured tubules are no longer able to in crease reabsorption of water, sodium, and urea. The specific gravity of the urine becomes isos thenuric, similar to plasma, and urinary sodium and fractional excretion of sodium and urea in crease to more than 20 mmol per liter, greater than 1%, and greater than 35%, respectively, while the ratio of blood urea nitrogen to creatinine falls back to 10:1. 3, 9, 10, 38 The urinary sediment will show sloughed renal tubular epithelial cells and debrisfilled, muddybrown, granular casts. Al though these elements are easily recognized by the nephrologist examining the urinary sediment, clinical laboratories may fail to identify them. 39 Laboratory personnel may not distinguish these pigmented casts from other granular casts and may not examine a sufficient number of fields on the slide to find them. Furthermore, the dip stick often shows no red cells, white cells, or proteinuria, so the clinical laboratory may not examine the sediment as part of the urinalysis. Many patients appear to be "between" prerenal azotemia and acute tubular necrosis because of mixed findings -for example, a ratio of blood urea nitrogen to creatinine of 25:1 and urinary sodium excretion of 15 mmol per liter, suggesting prerenal azotemia, but with renal tubular epi thelial cells in the urinary sediment, a finding that is consistent with acute tubular necrosis.
Ther a py a nd R e sp onse Lowperfusion states and risk factors for renal ischemia are often treatable and thus should be identified and dealt with promptly. If possible, blood pressure that is on the lower end of the normal range should be increased by correction of any hypovolemia and by dose reduction or dis continuation of antihypertensive medication and other medications that may lower blood pressure (e.g., narcotics). The patient should be evaluated for occult infection, and any such infection should be treated. If acute tubular necrosis has not yet occurred, effective therapy can reverse the in crease in the creatinine concentration within 24 to 48 hours. Improvement may even occur if only one of the causes is reversed -for example, stopping treatment with NSAIDs may be benefi cial in a patient with severe cardiomyopathy. How ever, if acute tubular necrosis has occurred, sev eral days are usually required before improvement is seen, even after the underlying causes have been treated. If the cause of acute renal failure is not apparent or if the patient's condition does not im prove, consultation with a nephrologist may help to ensure complete assessment and appropriate management. 40, 41 There are a number of considerations in treat ing patients with ischemic acute tubular necrosis. Since these persons are highly susceptible to re current renal damage, volume depletion, and hy potension, administration of NSAIDs and nephro toxic drugs, unnecessary anesthesia, surgery, and radiocontrast medium should be avoided. 41 How ever, critical surgical, imaging, and percutaneous procedures, such as transluminal coronary angio plasty in patients with acute myocardial infarc tion, should not be withheld or delayed if clini cally important harm might result. Prophylactic measures, such as administration of Nacetylcys teine, hydration, and low volumes of isoosmolol contrast agents, may reduce the risk of nephrop athy induced by contrast medium. 42 Enteral nutrition with food or formula designed for renal failure is preferred over parenteral nu trition, when possible, because it maintains the integrity of the gut, requires less fluid intake, and is less expensive. 41, 45, 46 Advice from a dieti tian or a nutrition consultant may be helpful. Although intake of potassium and phosphate is typically restricted because of impaired renal ex cretion, hypokalemia and hypophosphatemia due to cell uptake or external losses can occur, and supplements may be required.
Indications for intermittent or continuous renalreplacement therapy are florid uremic symp toms, volume overload, hyperkalemia, and meta bolic acidosis that cannot be managed by conser vative means. How severe these problems need to be before treatment is initiated is controversial. Arguments in favor of starting renalreplacement therapy early may be based on the desire to avoid the dangerous metabolic, fluid, and electrolyte derangements of uremia 47 ; arguments in favor of withholding renalreplacement therapy until definite indications are present are based on the risk of hemorrhage during vascular access, hypo tension and arrhythmia during dialysis, and pos sible dialysisinduced recurrent renal injury or delayed renal recovery. 48 Existing data on the tim ing of renalreplacement therapy are inadequate to provide clear guidance. 47, 49 Unfortunately, many patients with normotensive renal failure have important complicating factors, such as old age, sepsis, and heart disease, and progression to frank shock and death is not unusual.
C onclusions
An acute increase in the serum creatinine con centration is usually due to renal ischemia. If the patient does not have frank hypotension, normo tensive ischemic acute renal failure must be con sidered. A drop in systolic blood pressure to the lownormal range (100 to 115 mm Hg) must not be overlooked. Many cases can be treated quickly by replacing volume, treating infection, or stop ping medications such as NSAIDs, diuretics, and antihypertensive agents, especially ACE inhibitors or angiotensinreceptor blockers.
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